European Cervical Cancer Screening Network Work Group on Monitoring & Epidemiology

European guidelines for quality assurance in cervical cancer screening (draft 31.1.2003, A.Anttila)

CHAPTERS OF THE WORK GROUP ON EPIDEMIOLOGY (CHAPTERS 2, 9, 11)

2. Epidemiological guidelines for quality assurance in cervical cancer screening

2.0 Executive Summary A.Anttila

2.1 Introduction A.Anttila, with France-L and H.Vainio - proposed to include (to be checked also with the Introduction of the whole guideline!) Characterising age-standardised cervical cancer rates in Europe Brief description of current screening policies and activities in Europe Introduction to the chapter construction by discussing very briefly on the key elements required for a successful and effective programme

2.2 Organisation of the screening programme 2.2.1 Evidence-based screening policy for cervical cancer E.Lynge defining relevance and biologic background for cervical cancer screening discussing in detail screening policy recommendations (such as target age, screening interval, etc) and existing evidence behind the recommendations 2.2.2 An informed decision to initiate and run screening programmes for cervical cancer E.Lynge 2.2.3 Integration of an organised screening programme into the health care system M.Fender 2.2.4 Identification of relevant health care professionals, and their training M.Fender? 2.2.5 Local conditions for the screening process M.Fender 2.2.6 Communication Parts of the text provided by Greece-A, ...... Greece-O, UK, Spain

2.3 Implementation of the screening programme J.Patnick/E.McCoogan 2.3.1 Invitation scheme assistance (parts of the text from Greece-A, Greece-O) - includes also how to reach target population, and increase coverage & attendance 2.3.2 Screening process and further assessment J.Patnick/E.McCoogan 2.3.3 Stage of screen-detected pre-cancerous lesions and cancers J.Patnick/E.McCoogan 2.3.4 Treatment of screen-detected pre-cancerous lesions and cancers J.Patnick/E.McCoogan

1 2.4 Registration and data collection procedures 2.4.1 Registration and data collection of the screening programme A.Anttila 2.4.2 Data collecion of opportunistic smears A.Anttila, feed-back from M.Fender 2.4.3 Registration of cervical cancers A.Anttila, M.Hakama 2.4.4 Legal aspects of data registration M.Arbyn

2.5 Evaluation of the screening programme 2.5.1 Monitoring screening performance and outcomes G.Ronco 2.5.2 Evaluation of effectiveness M.Hakama 2.5.3 Designs and conditions in evaluating new technologies in the cervical cancer screening programmes A.Anttila, feed-back from M.Arbyn & J.Dillner 2.5.4 Ascertaining the programme by means of follow-up of cervical cancers in the target population A.Anttila 2.5.5 Cost-effectiveness N.N.

2.6 Bibliography

2.7 Glossary of terms

Appendix 1: Communication with patients

------

9. Data collection on treatment of screen-detected lesions P.Nieminen (see 1992 Guideline with section 5 "Monitoring on Programme" as well as the breast cancer screening guideline Chapter 9)

9.0 Executive summary

9.1 Main available computerised audit systems on surgical treatment of cervical lesions and cancers

9.2 Monitoring a European minimum set of outcome measures

9.3 Organisation of the audit procedures and resources required

9.4 References

------

11. Summary table of key performance indicators To be drafted by A.Anttila and G.Ronco, comments asked also from A.Miller

2